Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Portola Pharmaceuticals

Portola Pharmaceuticals
2003 FOUNDED
PUBLIC STATUS
301-400 EMPLOYEES
PTLA STOCK SYMBOL
1 INVESTMENTS
$28.05 SHARE PRICE (As of Monday Closing)
Description

Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Stock Exchange
NAS
Primary Office
  • 270 East Grand Avenue
  • South San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Portola Pharmaceuticals’s full profile, request a free trial.

Portola Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$14.81 - $37.95 $2.18B $28.45 -$4.13 969K 77.8M

Portola Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,850,439 1,140,456 2,714,557 999,029
Revenue 102,690 40,130 22,546 35,504
EBITDA (263,130) (342,218) (270,269) (267,661)
Net Income (282,535) (350,223) (286,090) (269,043)
Total Assets 577,185 386,419 571,676 343,436
Total Debt 293,598 215,356 104,816 49,815
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Portola Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Portola Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Portola Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Portola Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Portola Pharmaceuticals Competitors (58)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA 00 00.000 000000 - 000 00.000
000000000 00000000 Formerly VC-backed Charlottesville, VA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 00000000 00.000
0000000 Pending Transaction (M&A) Summit, NJ 0000 000.00 000000&0 000.00
00000000 Corporation Austin, TX 00 0000 00000000 0000
To view this company’s complete list of competitors, request access »

Portola Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 10-May-2007 00000 00000 00 000.00 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Portola Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 10-May-2007 00000 00000 00 000.00 Completed
  • 6 buyers
To view this company’s complete exits history, request access »

Portola Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Portola Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Portola Pharmaceuticals Executive Team (12)

Name Title Board
Seat
Contact
Info
Scott Garland Chief Executive Officer & Board Member
Dier Mardi Executive Vice President, Interim Co-Presidents, Board Member & Chief Financial Officer
Lee Mermelstein Ph.D Executive Director, Manufacturing and Biosciences
Ernie Meyer Executive Vice President & Executive
Dan Chen Vice President of Business Planning and Corporate Strategy

7 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Portola Pharmaceuticals Board Members (21)

Name Representing Role Since Contact
Info
Charles Homcy MD Self Board Member 000 0000
David Stump MD Self Board Member 000 0000
Dennis Fenton Ph.D Self Board Member 000 0000
Hollings Renton Self Chairman & Board Member 000 0000
H. Ward Wolff Self Board Member 000 0000

11 Former Board Members

You’re viewing 5 of 21 board members. Get the full list »